343 related articles for article (PubMed ID: 33198378)
41. TSP2 acts as a suppresser of cell invasion, migration and angiogenesis in medulloblastoma by inhibiting the Notch signaling pathway.
Pan W; Song XY; Hu QB; Zhang M; Xu XH
Brain Res; 2019 Sep; 1718():223-230. PubMed ID: 31063715
[TBL] [Abstract][Full Text] [Related]
42. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling.
Zeng Q; Li S; Chepeha DB; Giordano TJ; Li J; Zhang H; Polverini PJ; Nor J; Kitajewski J; Wang CY
Cancer Cell; 2005 Jul; 8(1):13-23. PubMed ID: 16023595
[TBL] [Abstract][Full Text] [Related]
43. Vasculogenic mimicry in carcinogenesis and clinical applications.
Luo Q; Wang J; Zhao W; Peng Z; Liu X; Li B; Zhang H; Shan B; Zhang C; Duan C
J Hematol Oncol; 2020 Mar; 13(1):19. PubMed ID: 32169087
[TBL] [Abstract][Full Text] [Related]
44. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.
Shi W; Harris AL
J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):41-52. PubMed ID: 16947085
[TBL] [Abstract][Full Text] [Related]
45. Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis.
Klose R; Adam MG; Weis EM; Moll I; Wüstehube-Lausch J; Tetzlaff F; Oka C; Ehrmann M; Fischer A
Oncogene; 2018 Aug; 37(31):4260-4272. PubMed ID: 29713059
[TBL] [Abstract][Full Text] [Related]
46. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
47. Recent insights into the role of Notch signaling in tumorigenesis.
Leong KG; Karsan A
Blood; 2006 Mar; 107(6):2223-33. PubMed ID: 16291593
[TBL] [Abstract][Full Text] [Related]
48. Targeting Notch signaling for cancer therapeutic intervention.
Shao H; Huang Q; Liu ZJ
Adv Pharmacol; 2012; 65():191-234. PubMed ID: 22959027
[TBL] [Abstract][Full Text] [Related]
49. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
[TBL] [Abstract][Full Text] [Related]
50. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
[TBL] [Abstract][Full Text] [Related]
51. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness.
Wang Z; Li Y; Kong D; Sarkar FH
Curr Drug Targets; 2010 Jun; 11(6):745-51. PubMed ID: 20041844
[TBL] [Abstract][Full Text] [Related]
52. Mammary Development and Breast Cancer: a Notch Perspective.
Chen W; Wei W; Yu L; Ye Z; Huang F; Zhang L; Hu S; Cai C
J Mammary Gland Biol Neoplasia; 2021 Sep; 26(3):309-320. PubMed ID: 34374886
[TBL] [Abstract][Full Text] [Related]
53. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
54. Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice.
Duan JL; Ruan B; Yan XC; Liang L; Song P; Yang ZY; Liu Y; Dou KF; Han H; Wang L
Hepatology; 2018 Aug; 68(2):677-690. PubMed ID: 29420858
[TBL] [Abstract][Full Text] [Related]
55. E-Prostanoid 3 Receptor Mediates Sprouting Angiogenesis Through Suppression of the Protein Kinase A/β-Catenin/Notch Pathway.
Chen D; Tang J; Wan Q; Zhang J; Wang K; Shen Y; Yu Y
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):856-866. PubMed ID: 28254818
[TBL] [Abstract][Full Text] [Related]
56. Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?
Saltarella I; Frassanito MA; Lamanuzzi A; Brevi A; Leone P; Desantis V; Di Marzo L; Bellone M; Derudas D; Ribatti D; Chiaramonte R; Palano MT; Neri A; Mariggiò MA; Fumarulo R; Dammacco F; Racanelli V; Vacca A; Ria R
Neoplasia; 2019 Jan; 21(1):93-105. PubMed ID: 30529074
[TBL] [Abstract][Full Text] [Related]
57. Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
Kumar S; Srivastav RK; Wilkes DW; Ross T; Kim S; Kowalski J; Chatla S; Zhang Q; Nayak A; Guha M; Fuchs SY; Thomas C; Chakrabarti R
Oncogene; 2019 Mar; 38(12):2092-2107. PubMed ID: 30442981
[TBL] [Abstract][Full Text] [Related]
58. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype.
Boareto M; Jolly MK; Goldman A; Pietilä M; Mani SA; Sengupta S; Ben-Jacob E; Levine H; Onuchic JN
J R Soc Interface; 2016 May; 13(118):. PubMed ID: 27170649
[TBL] [Abstract][Full Text] [Related]
59. Notch signaling in pediatric malignancies.
Zweidler-McKay PA
Curr Oncol Rep; 2008 Nov; 10(6):459-68. PubMed ID: 18928660
[TBL] [Abstract][Full Text] [Related]
60. Promoting angiogenesis to a fault.
Hicklin DJ
Nat Biotechnol; 2007 Mar; 25(3):300-2. PubMed ID: 17344881
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
